CDISC SEND Updates Nonclinical Drug Developers Need to Know
In this blog, Peggy Zorn explores updates to the Standard for Exchange of Nonclinical Data…
CertaraApril 6, 2026
Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib
This study demonstrates how a model-informed, totality-of-evidence approach was used to select the optimal clinical…
Danielle PillsburyApril 2, 2026
FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing
The FDA’s new draft guidance clarifies how drug developers can validate and use non-animal testing…
CertaraApril 1, 2026
6 ways Pinnacle 21 Enterprise centralized validation across studies
Learn how to centralize clinical data validation across studies using Pinnacle 21 Enterprise to improve…
CertaraApril 1, 2026
Transforming regulatory writing with CoAuthor™
Book a no-obligation demo to see how CoAuthor can revolutionize your regulatory writing processes.Accelerate submission…
Danielle PillsburyMarch 31, 2026
Certara Pinnacle 21 Enterprise CRF Creator
Manually designing CRFs and building EDCs causes delays in study setup. CRFs can't be fully…
Danielle PillsburyMarch 31, 2026
Certara Pinnacle 21 Data Exchange – Vendor Data Reconciliation Software
External vendors provide more than seventy percent of today's trial data without the help of…
Danielle PillsburyMarch 31, 2026
